The Day Novartis Chose Discovery(alexkesin.com)
22 points by quadrin | 8 comments
22 points by quadrin | 8 comments
166 points by vipshek | 166 comments
336 points by herbertl | 451 comments
A Substack essay by Todd Gagne arguing that GLP-1 weight-loss drugs could be a massive economic disruptor affecting jobs, investments, and industries.
344 points by vantareed | 197 comments
Nathan Lambert's Interconnects post arguing that the GLM-5.2 model marks a capability threshold for open-weight agentic AI.
411 points by giuliomagnifico | 748 comments
Cornell Chronicle article on research finding that GLP-1 drugs like Ozempic and Wegovy are associated with reductions in Americans' grocery and food purchases.
136 points by dzink | 121 comments
University of California news article reporting a UC San Diego study suggesting a popular GLP-1 weight loss drug may slow biological aging.
335 points by pseudolus | 524 comments
Ars Technica article reporting that teen drug use continued an unprecedented decline in 2024, with the pandemic-era cohort showing high rates of abstaining.
438 points by cainxinth | 432 comments
Article reporting on an MIT study claiming that using AI tools like ChatGPT alters brain activity and leads to cognitive decline.
365 points by randycupertino | 399 comments
CTV News article reporting that OpenAI updated ChatGPT usage policies to disallow providing tailored legal and medical advice.